Enhanced antidepressant effect of sigma(1) (sigma(1)) receptor agonists in beta(25-35)-amyloid peptide-treated mice (Q44111429)

29 November 2017

Enhanced antidepressant effect of sigma(1) (sigma(1)) receptor agonists in beta(25-35)-amyloid peptide-treated mice (English)

1 reference

29 November 2017

1

Alexandre Urani

1 reference

29 November 2017

Pascal Romieu

2

1 reference

29 November 2017

François J Roman

series ordinal

3

1 reference

29 November 2017

Tangui Maurice

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Behavioural Brain Research

29 November 2017

1 reference

29 November 2017

134

1 reference

29 November 2017

1-2

1 reference

29 November 2017

239-247

1 reference

Modification of the N-methyl-D-aspartate response by antidepressant sigma receptor ligands

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Depression in Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Pathways of neurosteroid biosynthesis in cell lines from human brain: regulation of dehydroepiandrosterone formation by oxidative stress and beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Serotonin in Alzheimer-type dementia and other dementing illnesses.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Depression, cognitive impairment and function in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Depression and risk of cognitive decline and Alzheimer's disease. Results of two prospective community-based studies in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Purification, molecular cloning, and expression of the mammalian sigma1-binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Diagnostic evaluation of 200 elderly outpatients with suspected dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Sigma 1 receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Neurosteroids ameliorate conditioned fear stress: an association with sigma receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Modulation of steroidal levels by adrenalectomy/castration and inhibition of neurosteroid synthesis enzymes affect sigma1 receptor-mediated behaviour in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Depressive symptoms in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Depressive illness, depressive symptomatology and regional cerebral blood flow in elderly people with sub-clinical cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Neurosteroids Biosynthesis and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

JO 1784, a potent and selective ligand for rat and mouse brain sigma-sites

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Hippocampal atrophy in recurrent major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Sertraline potently displaces (+)-[3H]3-PPP binding to sigma sites in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Tianeptine versus fluoxetine in the treatment of depression complicating Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Effects of doses of fragment (25-35) of beta-amyloid peptide on behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Brain oestradiol and testosterone levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Beneficial effects of acute and repeated administrations of sigma receptor agonists on behavioral despair in mice exposed to tail suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (sigma1) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Overview of depression and psychosis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Animal models of Alzheimer's disease and evaluation of anti-dementia drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

Sigma receptor ligands (+)-SKF10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2802%2900033-5

7 January 2021

10.1016/S0166-4328(02)00033-5

Identifiers

DOI

1 reference

29 November 2017

1 reference